Dylan Lauri Steen MD

PubMed

• Guideline-based lipid-lowering therapy in acute coronary syndromes: A simulation of population-level impact on cardiovascular events and LDL-C goal achievement.
  Dylan L Steen, Kausik K Ray, Irfan Khan, Alberico L Catapano, Deepak L Bhatt
  Journal of Clinical Lipidology. 2026-05-01
• PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study.
  Richard C Becker, Brett Harnett, Donald Wayne, Rachael Mardis, Karthikeyan Meganathan
  Clinical Research in Cardiology. 2025-04-01
• 14 citations
  Efficacy of supermarket and web-based interventions for improving dietary quality: a randomized, controlled trial.
  Dylan L Steen, Robert N Helsley, Deepak L Bhatt, Eileen C King, Suzanne S Summer
  Nature Medicine. 2022-12-01

Journal Articles

• The Effect of Fasting Status on Lipids, Lipoproteins, and Inflammatory Biomarkers Assessed After Hospitalization for an Acute Coronary Syndrome: Insights from PROVE IT...  
  Dylan L Steen, Naseer Khan, Clinical Cardiology
• Widening the Path and Window of Opportunity for FDA Approval of Non-Vitamin K Oral Anticoagulant Specific Antidotes and Reversal Agents  
  Patel S, Steen DL, Journal of Thrombosis and Thrombolysis, 1/15/2015
• Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial  
  O'Donoghue ML, Braunwald E, White HD, Steen DL, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wivio..., JAMA, 1/31/2014

Abstracts/Posters

• Prognostic Utility of Fibroblast Growth Factor-23 after an Acute Coronary Syndrome
  Udell JA, Morrow DA, Braunwald E, Cannon CP, Steen DL, Jarolim P, Lukas MA, Budaj A, Hamm C, Zhou J, Im K, Sabatine MS, O’Donoghue ML, ACC, 1/1/2015
• Galectin-3 for Heart Failure Risk Stratification in Patients After ACS: Insights from the SOLID-TIMI 52 trial
  Magnani G, O’Donoghue ML, Braunwald E, Steen DL, Jarolim P, Lukas MA, White HD, Lewis B, de Winter RJ, Zhou J, Im K, Cannon CP, Morrow DA, AHA, 1/1/2015
• Performance Reports and the Utilization of Guideline-Based Therapies in a Large Clinical Trial Population Enrolled after an Acute Coronary Syndrome: Insights from the...
  Steen DL, Cannon CP, Daga S, Lukas MA, Ophuis TO, Gratsiansky N, Crugnale S, Shannon J, O’Donoghue ML, ACC, 1/1/2015

Other

• The Revised ACC/AHA/HRS Guidelines for the Management of Patients With Atrial Fibrillation 
  Steen DL
  1/25/2014
• A Middle-Aged Man With AFib and Mechanical Heart Valve 
  Steen DL
  1/15/2013
• HDL and CETP Inhibition 
  Steen DL, Wiviott SD, Cannon CP
  http://www.cardiosource.org/Science-And-Quality/Expert-Opinions-and-Cases/Hot-Topics/2012/02/HDL-and-CETP-Inhibition.aspx
  1/17/2012